US2021284758A1PendingUtilityA1
Polymer-cyclic molecule structure and method for producing the same
Est. expiryFeb 20, 2040(~13.6 yrs left)· nominal 20-yr term from priority
B82Y 30/00C08B 37/0015A61K 9/5036B82Y 5/00A61K 47/61A61K 9/5031B82Y 40/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided is a structure including a plurality of pseudo-polyrotaxanes and/or polyrotaxanes each including a chain polymer included in a cavity or cavities of one or more cyclic molecules in a skewered manner, at least part of the plurality of pseudo-polyrotaxanes and/or polyrotaxanes being arranged in series with each other.
Claims
exact text as granted — not AI-modified1 . A structure comprising a plurality of pseudo-polyrotaxanes and/or polyrotaxanes each including a chain polymer included in a cavity or cavities of one or more cyclic molecules in a skewered manner, at least part of the plurality of pseudo-polyrotaxanes and/or polyrotaxanes being arranged in series with each other.
2 . The structure according to claim 1 , wherein the chain polymer is a single chain.
3 . The structure according to claim 1 , wherein the chain polymer is included in the cavities of the three or more cyclic molecules per one chain polymer in a skewered manner.
4 . The structure according to claim 1 , wherein at least part of the plurality of pseudo-polyrotaxanes and/or polyrotaxanes are arranged in parallel with each other.
5 . The structure according to claim 1 , further comprising a substance that is bonded to the chain polymer, is bonded to the cyclic molecule, or is held in one of a space between the plurality of pseudo-polyrotaxanes and/or polyrotaxanes, the cavity defined and formed by the one cyclic molecule, and a space defined and formed by the plurality of cyclic molecules.
6 . The structure according to claim 5 , wherein the substance is at least one selected from the group consisting of a drug, a fluorescent substance, and a chromogenic enzyme.
7 . The structure according to claim 1 , wherein the chain polymer has a length of from 1 nm to 2,000 nm.
8 . The structure according to claim 1 , wherein the chain polymer includes a moiety formed of one of polyethylene glycol (PEG) or polypropylene glycol (PPG).
9 . The structure according to claim 1 , wherein the cyclic molecule is at least one selected from the group consisting of a cyclodextrin, a crown ether, a pillararene, a calixarene, a cyclophane, and derivatives thereof.
10 . The structure according to claim 1 , wherein the structure has arranged therein at least one through-hole penetrating the structure and occupying a space larger than a volume occupied by the one pseudo-polyrotaxane and/or polyrotaxane.
11 . The structure according to claim 1 , wherein the structure is any one of the following (a) to (c):
(a) a rod-shaped structure in which the chain polymer has a weight-average molecular weight of from 200 to 10,000; (b) a cube-shaped structure in which the chain polymer has a weight-average molecular weight of from 1,000 to 20,000; and (c) a sheet-shaped structure in which the chain polymer has a weight-average molecular weight of from 2,000 to 200,000.
12 . A method of producing a structure including a plurality of pseudo-polyrotaxanes and/or polyrotaxanes each including a chain polymer included in a cavity or cavities of one or more cyclic molecules in a skewered manner, the method comprising causing the plurality of pseudo-polyrotaxanes and/or polyrotaxanes each including the chain polymer having both ends housed in a column formed of the plurality of cyclic molecules to interact with each other to arrange at least part of the plurality of pseudo-polyrotaxanes and/or polyrotaxanes in series with each other.Join the waitlist — get patent alerts
Track US2021284758A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.